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Abstract, The purpose of this study was to establish the influence of hypertonic saline solution 7,5% perfusion 
on erythrocyte function and morphology in condition of post hemorrhagic hypovolemic shock state on dogs.  
The research was carried out on 22 indefinite half-breed dogs on which under anesthesia, were induced the 
hemorrhagic shock, and the reequilibration therapy with hypertonic saline solution administrated by intravenous 
or intra-arterial route was applied. In order to highlight the changes of the erythrocyte diameter were prepared 
some blood smears, colored May-Grünwald-Giemsa, that were examined with a 90 object lens. The pulse 
oximetry assessing brings us information about the gas exchange at pulmonary level and indirectly about 
erythrocyte capacity to binding and carrying oxygen. The obtained results demonstrates the fact that the use of 
hypertonic saline solution does not compromise the erythrocyte function  and in context of microcirculatory 




In the field of emergency medicine, it was funded the so-called “small-volume 
resuscitation”, when it is the patient who has most to gain after the blood volume recovery with 
the help of the perfusion with hyperosmolar solution (5, 8, 12). The hypertonic saline solution 
7,5% (HSS) is worth a particular attention because the perspectives of its usage arises great 
interest not only for precocious therapy of hemorrhagic shock, but also for other hypotensive 
states. The action mechanism of hypertonic sodium chloride solution is not yet fully understood 
(8, 11). There are studies that attribute the effects obtained only to the mechanisms dependent to 
the blood volume refilling by hyperosmolarity. There is also the hypothesis according to which, 
in case of hemorrhagic shock, there are also some nervous ways involved and activated, among 
which the most important one is that from the lung area (1, 11). According to these standpoints, 
we considered to be important to establish the influence of this therapy on the level of 
erythrocyte at the same time with the validation of the therapeutic effect of HSS perfusion. 
   
MATERIAL AND METHODS 
 
The research was carried out on 22 healthy indefinite half-breed dogs, of both sexes (13 
males and 9 females), of an age between 1-4 years, with a weight between 7-16,5 kg. The 
animals were got ready for the experiment by redraw food 12 hours and water one hour before 
the anesthesia. They were divided in one control group and two experimental groups. Under 
general anesthesia, were induced the hemorrhagic shock. The reequilibration therapy was 
different according to the group: - in the experimental group I, the HSS 7,5%, 4ml/kg was 
intravenous (I.V.) administrated; - in the experimental group II, the HSS 7,5% 4ml/kg was 
 218 
intra-arterial (I.A.) administrated; - in the control group, the NaCl 0,9%, 33 ml/kg, quantity 
equivalent in mmol of Na+ and Cl-, was I.V. administrated. In all three groups, before (control 
values) and after the shock, at the end of the perfusion and during the postreequilibration 
phase, at intervals of 5 minutes, were monitored a series of hemodynamic parameters, 
relevant for this study being pulse oximetry, that means noninvasive measurement of SaO2 by 
attaching a sensor on the animal’s tongue (monitor Kontron Minimon 7138B). The last 
measurements were recorded after 60 minutes from the beginning of the resuscitation therapy.  
In order to highlight the changes of the erythrocyte diameter, before the perfusion with HSS 
and 5, 15 and 30 minutes after the perfusion, it prepared some blood smears, colored May-
Grünwald-Giemsa, that were examined with a 90 object lens, while it recorded the number of 
divisions at 100 erythrocytes. Subsequently, it corrected it with the average value of 1,07µ, by 
calculating the diameter of each erythrocyte. The result was the average of diameters.  
Data were analyzed using the T-student test for comparison within the group Values are 
expressed as mean±SEM, the values of p<0,05 were considered to be significant. 
 
RESULTS AND DISCUSSIONS 
 
The erythrocyte diameter in the experimental groups decreased significantly as 
compared to the control values, immediately after the perfusion with HSS, from 7,13±0,06 to 
6,65±0,6 µ 5 minutes after the I.V. HSS perfusion and from 7,08±0,13 to 6,68±0,15 µ in the 
I.A. perfused group. The reduction of the erythrocyte diameter observed at minute 5 could be 
observed in both groups and in the smears prepared during the last blood collection (minute 
30). The individual medium values as well as the group average were rendered in table 1. 
In the control group, there were no significant diameter changes, except for minute 30 
when the values increased significantly (7,12±0,06 control value, 7,20±0,7 µ at minute 30), a 
phenomenon that could be interpreted as the onset of erythrocyte oedemation. he dehydration 
of red cells caused by the hyperosmolar effect of HSS reduced the difference between the 
erythrocyte diameter and the capillary one. This phenomenon, together with modifications 
regarding packet cell volume and blood viscosity recorded too, contributed to the visible 
amelioration of microcirculation (4, 6, 7). In the experimental hemorrhagic shock SaO2 
dropped significantly; from normal values to 74,83±3,05 (group infused I.V. with HSS), 
71,75±2,29 (group I.A. infused with HSS) or 75,33±3,17% (control group) (table 2).  
After the reequilibration, SaO2 underwent visible changes in all groups (table 2). The 
I.V perfusion with HSS induced the increase of SaO2 within individual limits of 80-99% and 
medium limits of 91,44±1,94 - 93±1,33%, which denoted the disappearance of the state of 
hypoxemia. On two subjects were recorded short periods of hypoxemic state but without 
impairment of reading the signal. The hypoxemic state identified during shock period was 
find on all subjects of experimental group II at the end of the perfusion phase, a different 
situation was find on experimental group I on which only 44,4% of subjects were hypoxemic 
on that moment. After I.A. perfusion of HSS SaO2 was between 72-99%, and medium values 
between 84,40±3,61 – 93,50±1,55%. The impossibility to reading a signal during this period 
of time was appeared on 10% of measurements, results of weak pulse pressure that can’t be 
detected by the sensor. In the case of the control group, at the end of the perfusion with 33 
ml/kg normal saline, 87,5% of the subjects were hypoxemic (SaO2 below 85%). The inferior 
SaO2 limit in the immediately next period, that of reequilibration phase, was of 66% while the 
superior one was of 99%, the medium values being between 86,63±3,33 - 91,14±2,57. In this 




Table 1   
Individual and group medium (x±SEM) values of erythrocyte diameter (µ)  
at different time intervals after I.V. and I.A. HSS perfusion 
 
Crt. no. before the 
treatment 
at 5 minutes after 
the perfusion 
at 15 minutes 
after the 
perfusion 
at 30 minutes 
after the 
perfusion 
Experimental group I (SSH administrated by I.V. way) 
1 7,1304 6,5270 6,5056 6,5270 
2 7,5542 6,8266 6,8480 6,8694 
3 7,2118 6,6126 6,6768 6,5056 
4 6,8694 6,2488 6,2488 6,2274 
5 7,2118 6,5912 6,5270 6,5484 
6 7,1048 6,4414 6,4842 6,4628 
7 7,1690 6,5484 6,5270 6,5056 
8 7,0406 6,3986 6,3130 6,3344 
9 6,9378 6,7838 6,7624 6,7410 
x±SEM 7,1366±0,0654 6,5532±0,0604 6,5436±0,0650 6,5246±0,0640 
Experimental group II (SSH administrated by I.A. way) 
10 6,9764 6,2060 6,2488 6,2916 
11 7,1048 7,0620 6,9764 6,9336 
12 7,0085 6,8694 6,8266 6,8480 
13 7,5649 6,8480 6,8694 6,8908 
14 6,7838 6,4628 6,4200 6,4414 
x±SEM 7,0876±0,1302 6,6896±0,1552 6,6682±0,1411 6,6810±0,1313 
Control group (NaCl 0,9% solution administrated I.V.) 
15 7,1904 7,0192 7,1904 7,1904 
16 6,9764 6,9764 7,0406 7,0834 
17 6,9978 6,955 6,8266 6,9778 
18 7,062 7,0727 7,0834 7,1048 
19 7,4692 7,4044 7,5649 7,6612 
20 6,955 6,955 7,0085 7,062 
21 7,1476 7,2118 7,2332 7,2546 
22 7,2332 7,2374 7,3596 7,3016 
x±SEM 7,1290±0,0607 7,1040±0,0580 7,1634±0,0807 7,2045±0,0753 
 
The values of SaO2 recorded during shock development phase show that massive blood 
loss is accompanied by hypoxemia, confirming data obtained by other researcher (8, 9, 13). 
Oxygen hiposaturation of arterial blood play an important role in development of tissue 
hypoxia. The efficient functioning of the hemodynamic mechanisms after the I.V. perfusion 
with HSS, recorded in similar studies carried out not only on dogs but also on other species (2, 
3, 10, 13), was also proved by its ensuring the correspondent blood oxygen binding, needed by 
heart and tissues. By hyperosmolarity induced in microcirculation, HSS triggered a series of 
events, which contributed to the improvement of lung circulatory conditions (improvement of 
lung arterial flux, minimization of vascular resistance by modulation of baroreceptors as a result 
of the increase of pulse pressure amplitude by reduction of frequency). It also contributed to the 
improvement of the gas exchange at this level, which had an ulterior influence on the whole 
organism. All these phenomena show us that functionality of erythrocytes was conserved, 
despite of the fact that the osmotic maintaining of erythrocyte shape is one of the essential 






Medium values (x±SEM) of SaO2 (%) during the surveillance period  
Time 





























































































































 The erythrocyte diameter is significantly reduced by HSS, indifferent by route of 
administration, decreasing from 7,13±0,06 la 6,65±0,6 µ at 5 minutes after I.V. perfusion 
and from 7,08±0,13 to 6,68±0,15 µ after I.A. perfusion.  
 HSS counteract the oedemation tendency of erythrocytes established on control group on 
which medium value of erythrocyte diameter was increased from 7,12±0,06 µ (control 
value) to 7,20±0,7 µ (medium value at 30 minutes). It can be said that HSS protect the 
erythrocyte against post ischemic oedemation, improving microcirculatory status.  
 I.V. perfusion with HSS, by favourable effect on pulmonary circulation, increases and 
maintains percentage of hemoglobin saturation at 80-99%; a hypoxemic transitory state 
was identified on two subjects. Comparative weakly results (72% a minimum value of 
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